专题：Cutaneous Melanoma Detection and Management

This cluster of papers focuses on the diagnosis, treatment, and epidemiology of melanoma, a type of skin cancer. It covers topics such as dermatologist-level classification, genetic alterations, sentinel lymph node biopsy, immunotherapy, tumor staging, deep learning for melanoma recognition, and survival analysis. The papers also discuss the epidemiological trends and risk factors associated with melanoma.
最新文献
Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase IIb KEYNOTE-942 Study

article Full Text OpenAlex

Performance Evaluation of Handcrafted Feature Descriptors for Skin Disease Classification using Decision Tree Classifier

conference-paper Full Text OpenAlex

Evaluating Machine Learning Classifiers with Binary Pattern Pyramid Features for Efficient Skin Disease Classification

conference-paper Full Text OpenAlex

Emerging biomarkers in melanoma: Bridging molecular discovery and precision oncology

review Full Text OpenAlex

DermaGPT a federated multimodal framework with a meta learned trust function for interpretable dermatology diagnostics

article Full Text OpenAlex

Highly Accurate Skin Cancer Diagnosis Using HMT-NET and Vision Transformer Models

article Full Text OpenAlex

Equity and Generalizability of Artificial Intelligence for Skin-Lesion Diagnosis Using Clinical, Dermoscopic, and Smartphone Images: A Systematic Review and Meta-Analysis

review Full Text OpenAlex

Vitiligo

review Full Text OpenAlex

Identification and validation of prognostic genes and prognostic models associated with cutaneous melanoma and integrative stress response

article Full Text OpenAlex

WHO classification of skin tumours: key updates in the fifth edition

review Full Text OpenAlex

近5年高被引文献
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma

article Full Text OpenAlex 1905 FWCI166.8384

Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040

article Full Text OpenAlex 1499 FWCI122.8829

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

article Full Text OpenAlex 917 FWCI114.1542

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study

article Full Text OpenAlex 905 FWCI157.6331

Cutaneous melanoma

review Full Text OpenAlex 729 FWCI24.357

A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance

review Full Text OpenAlex 572 FWCI15.5231

Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma

article Full Text OpenAlex 561 FWCI85.5539

Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma

article Full Text OpenAlex 553 FWCI83.3679

Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma

article Full Text OpenAlex 550 FWCI49.193

Disparities in dermatology AI performance on a diverse, curated clinical image set

article Full Text OpenAlex 541 FWCI35.1858